arrow_back Back to App

Access to Medicines and Transparency in Military-Funded Medical Research

This act aims to increase access to drugs, vaccines, and medical technologies developed with Department of Defense financial support. Citizens may gain easier access to these products. Additionally, the act mandates the creation of a public database to show how taxpayer money is spent on medical research, increasing transparency in public expenditures.
Key points
Increased access to drugs and vaccines: The Department of Defense must allow other entities to use medical technologies to make them more widely available to military personnel and civilians.
Transparency of public spending: A public, easily accessible database will be created to show how taxpayer money is used for medical research, including the development of drugs and vaccines.
Information on prices and production: The database will include information on the prices of medical products developed with public support and their production capacities.
Penalties for non-disclosure: Companies that received public support and fail to disclose required information may be fined.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_2486
Sponsor: Sen. Warren, Elizabeth [D-MA]
Process start date: 2021-07-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Make Taxpayer-Funded Department of Defense Medical Interventions Affordable Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_2486.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-07-27.

What are the main provisions?

Key points include:

  • Increased access to drugs and vaccines: The Department of Defense must allow other entities to use medical technologies to make them more widely available to military personnel and civilians.
  • Transparency of public spending: A public, easily accessible database will be created to show how taxpayer money is used for medical research, including the development of drugs and vaccines.
  • Information on prices and production: The database will include information on the prices of medical products developed with public support and their production capacities.
  • Penalties for non-disclosure: Companies that received public support and fail to disclose required information may be fined.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Warren, Elizabeth [D-MA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Public Investments